Cours A.P. Pharma, Inc. Other OTC
Actions
US00202J2033
Recherche biotechnologique et médicale
Cours en clôture
Autres places de cotation
|
||
- USD | - |
|
CA 2024 * | 148 M 132 M | CA 2025 * | 178 M 159 M | Capitalisation | 432 M 387 M |
---|---|---|---|---|---|
Résultat net 2024 * | -14 M -12,53 M | Résultat net 2025 * | 1 M 895 k | VE / CA 2024 * | 2,92 x |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 2,43 x |
PER 2024 * |
-31,9
x | PER 2025 * |
430
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 99,3% |
Dernier transcript sur A.P. Pharma, Inc.
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 21/02/23 |
Ira Duarte
DFI | Director of Finance/CFO | 55 | 16/06/23 |
Chris Storgard
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/11/18 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 21/02/23 |
Susan Rodriguez
BRD | Director/Board Member | 60 | 20/09/21 |
Craig Johnson
BRD | Director/Board Member | 62 | 13/01/14 |
Varia. 1 janv. | Capi. | |
---|---|---|
+18,97% | 45,34 Md | |
+41,98% | 40,42 Md | |
-10,06% | 37,92 Md | |
+31,15% | 31,75 Md | |
-7,79% | 27,71 Md | |
+13,32% | 26,52 Md | |
+43,05% | 13,96 Md | |
+31,28% | 12,44 Md | |
-7,41% | 11,26 Md |
- Bourse
- Actions
- Action HRTX
- Action